Tech Company Financing Transactions

M3 Biotechnology Funding Round

Alzheimer's Drug Discovery Foundation joined a $1.4 million funding round for M3 Biotechnology. The financing was announced on 4/17/2017.

Transaction Overview

Company Name
Announced On
4/17/2017
Transaction Type
Venture Equity
Amount
$1,400,000
Round
Undisclosed
Investors
Proceeds Purpose
The fund makes early stage investments in the most promising Alzheimer's-specific therapeutics which require funding for the critical phase of translating successful animal therapies to human clinical trials.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4000 Mason Rd. Box 352141 300
Seattle, WA 98195
USA
Email Address
Overview
M3 Biotechnology is a therapeutics company with a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative diseases like Alzheimer's.
Profile
M3 Biotechnology LinkedIn Company Profile
Social Media
M3 Biotechnology Company Twitter Account
Company News
M3 Biotechnology News
Facebook
M3 Biotechnology on Facebook
YouTube
M3 Biotechnology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Leen Kawas
  Leen Kawas LinkedIn Profile  Leen Kawas Twitter Account  Leen Kawas News  Leen Kawas on Facebook
Chief Financial Officer
Glenna Mileson
  Glenna Mileson LinkedIn Profile  Glenna Mileson Twitter Account  Glenna Mileson News  Glenna Mileson on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/17/2017: TheWaveVR venture capital transaction
Next: 4/18/2017: Gravity Supply Chain venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary